Given the mild nature of relapses, as compared to the onset of TTP events, the need for sensitive, predictive biomarkers should drive a deeper exploration of ADAMTS13-related parameters, in particular right before acute relapses. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.